Gao Q, Jia Y, Yang G, Zhang X, Boddu PC, Petersen B, Narsingam S, Zhu YJ, Thimmapaya B, Kanwar YS, Reddy JK (2015) PPARalpha-deficient ob/ob obese mice become more obese and manifest severe hepatic steatosis due to decreased fatty acid oxidation
Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss
Pediatr Nephrol 16:862867 Rajpoot DK, Gargus JJ (2004) Acute hemodialysis for hyperammonemia in small neonates
Glutathione Research in Parkinsons Disease Biological rationale and small trials have not established a proven treatment
[20] [9] If severe abdominal pain develops during GLP-1 agonist treatmentparticularly if it persists for several hours or is accompanied by repeated vomitingpatients should stop taking the medication and seek immediate medical assessment